Clozapine and tardive movement disorders: A review

Asian Journal of Psychiatry

Volumn 6, Issue 6, 2013, Pages 439-451

  Hazari, Nandita ^a   Kate, Natasha ^a   Grover, Sandeep ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Clozapine; Tardive dyskinesia; Tardive dystonia; Tardive syndromes

Indexed keywords

BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CLONAZEPAM; CLOZAPINE; DIAZEPINE DERIVATIVE; HALOPERIDOL; NEUROLEPTIC AGENT;

BLEPHAROSPASM; CEREBRAL PALSY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EXPOSURE; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; HUMAN; MEDICATION COMPLIANCE; MEIGE SYNDROME; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TARDIVE MOVEMENT SYNDROME; TORTICOLLIS; TREATMENT OUTCOME;

CLOZAPINE; TARDIVE DYSKINESIA; TARDIVE DYSTONIA; TARDIVE SYNDROMES;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DYSKINESIA, DRUG-INDUCED; HUMANS; PSYCHOTIC DISORDERS;

EID: 84888871656     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2013.08.067     Document Type: Review

References (92)

1. Abraham J.T., Brown R., Meltzer H.Y. Clozapine treatment of persistent paroxysmal dyskinesia associated with concomitant paroxetine and sumatriptan use. Biol. Psychiatr. 1997, 42:144-146.
2. Adityanjee, Lindenmeyer J.P. Precipitation of dystonia by m-CPP in a schizophrenic patient treated with haloperidol. Am. J. Psychiatr. 1993, 150:837-838.
3. Adityanjee, Estrera A.B. Successful treatment of tardive dystonia with clozapine. Biol. Psychiatr. 1996, 39:1064-1065.
4. Adityanjee, Yekeen A., Aderibigbe V., Chowdary J., Mathews T. The current status of tardive dystonia. Biol. Psychiatr. 1999, 45:715-730.
5. Ahmed S., Chengappa K.N., Naidu V.R., Baker R.W., Parepally H., Schooler N.R. Clozapine withdrawal emergent dystonias and dyskinesias: a case series. J. Clin. Psychiatr. 1998, 59:472-477.
6. Arora M., Praharaj S.K., Sarkar S. Clozapine effective in olanzapine-induced Pisa syndrome. Ann. Pharmacother. 2006, 40:2273-2275.
7. Aukst-Margetić B., Margetić B. Treatment of generalized tardive dystonia with clozapine. Psychiatr. Danub. 2008, 20:329-331.
8. Bajulaiye R., Addonizio R. Clozapine in the treatment of psychosis in an 82-year-old woman with tardive dyskinesia. J. Clin. Psychopharmacol. 1992, 12:364-365.
9. Bassitt D.P., Louza-Neto M.R. Clozapine efficacy in tardive dyskinesia in schizophrenic patients. Eur. Arch. Psychiatr. Clin. Neurosci. 1998, 248:209-211.
10. Bhidayasiri R., Boonyawairoj S. Spectrum of tardive syndromes: clinical recognition and management. Postgrad. Med. 2011, 87:132-141.
11. Bolden C., Cusack B., Richelson E. Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells. Eur. J. Pharmacol. 1991, 192:205-206.
12. Bruneau M.A., Stip E. Metronome or alternating Pisa syndrome: a form of tardive dystonia under clozapine treatment. Int. Clin. Psychopharmacol. 1998, 13:229-232.
13. Bruscas M.J., Gonzalez F., Santos J.L., Sánchez E. Tardive dyskinesia associated with clozapine treatment. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 2007, 31:963-964.
14. Carroll B.J., Curtis G.C., Kokmen E. Paradoxical response to dopamine agonists in tardive dyskinesia. Am. J. Psychiatr. 1977, 134:785-789.
15. Chakrabarti S., Chand P.K. Lithium-induced tardive dystonia. Neurol. India 2002, 50:473-475.
16. Chengappa K.N., Shelton M.D., Baker R.W., Schooler N.R., Baird J., Delaney J. The prevalence of akathisia in patients receiving stable doses of clozapine. J. Clin. Psychiatr. 1994, 55:142-145.
17. Cole J.O., Gardos G., Tarsy D. Drug trials in persistent dyskinesia. Tardive Dyskinesia, Research and Treatment 1980, 419-427. SP Medical and Scientific Books, New York. W.E. Fann, R.C. Smith, J.M. Davis, E.F. Domino (Eds.).
18. Conus P., Zullino D., Baumann P. Clozapine is more efficacious for tongue dystonia than olanzapine. Psychopharmacol. (Berl.) 2002, 162:89.
19. Dalack G.W., Becks L., Meador-Woodruff J.H. Tardive dyskinesia, clozapine and treatment response. Prog. Neuro-Psychophamacol. Biol. Psychiatr. 1998, 22:567-573.
20. Dave M. Tardive oculogyric crises with clozapine. J. Clin. Psychiatr. 1994, 55:264-265.
21. Dave M. Clozapine-related tardive dyskinesia. Biol. Psychiatr. 1994, 35:886-887.
22. Delecluse F., Elosegi J.A., Gerrard J.M. A case of tardive tremor successfully treated with clozapine. Mov. Disord. 1998, 83:846-847.
23. Duggal H.S., Mendhekar D.N. Clozapine-induced tardive dystonia (blepharospasm). J. Neuropsychiatr. Clin. Neurosci. 2007, 19:86-87.
24. Ertugrul A., Demir B. Clozapine-induced tardive dyskinesia: a case report. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 2005, 29:633-635.
25. Fakra E., Azorin J.M. Clozapine for the treatment of schizophrenia. Expert Opin. Pharmacother. 2012, 13:1923-1935.
26. Fehsel K., Loeffler S., Krieger K., Henning U., Agelink M., KolbBachofen V., Klimke A. Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients. J. Clin. Psychopharmacol. 2005, 25:419-426.
27. Friedman J.H. Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases. Mov. Disord. 1994, 9:321-324.
28. Garcia-Lado I., Garcia-Caballero A., Recimil M.J., Area R., Ozaita G., Lamas S. Reapperance of tardive dystonia with olanzapine treated with clozapine. Schizophr. Res. 2005, 76:357-358.
29. Gerbino L., Shopsin B., Collora M. Clozapine in the treatment of tardive dyskinesia: an interim report. Tardive Dyskinesia, Researchand Treatment 1980, 475-489. SP Medical and Scientific Books, New York. W.E. Fann, R.C. Smith, J.M. Davis, E.F. Domino (Eds.).
30. Gerlach J., Koppelhus P., Helweg E., Monrad A. Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr. Scand. 1974, 50:410-424.
31. Hanagasi H.A., Bilgic B., Gurvit H., Emre M. Clozapine treatment in oromandibular dystonia. Clin. Neuropharmacol. 2004, 27:84-86.
32. Havaki-Kontaxaki B.J., Kontaxakis V.P., Margariti M.M., Paplos K.G., Christodoulou G.N. Treatment of severe neuroleptic-induced tardive torticollis. Ann. Gen. Hosp. Psychiatr. 2003, 2:9-11.
33. Huang W.L., Chang H.C., Tsai Y.F., Chang L.R., Liu C.M. Aripiprazole augmentation for clozapine-associated tardive torticollis. J. Neuropsychiatr. Clin. Neurosci. 2012, 24:E49.
34. Hung T.H., Lee Y., Chang Y.Y., Chong M.Y., Lin P.Y. Reversible Pisa syndrome induced by clozapine: a case report. Clin. Neuropharmacol. 2007, 30:370-372.
35. Jaffe E., Tromeau F., Sharif Z., Reider R. Clozapine in tardive tourette syndrome. Biol. Psychiatr. 1995, 38:196-197.
36. Kalian M., Lerner V., Goldman M. Atypical variants of tardive dyskinesia, treated by a combination of clozapine with propranolol and clozapine with tetrabenazine. J. Nerv. Ment. Dis. 1993, 181:649-651.
37. Kane J.M., Woerner M.G., Pollack S., Safferman A.Z., Lieberman J.A. Does clozapine cause tardive dyskinesia?. J. Clin. Psychiatr. 1993, 54:327-330.
38. Karp B.I., Goldstein S.R., Chen R., Samii A., Bara-Jimenez W., Hallett M. An open trial of clozapine for dystonia. Mov. Disord. 1999, 14:652-657.
39. Kimiagar I., Prokhorov T., Rabey J.M., Dobronevsky E., Miniovitz A. Rapid improvement of tardive dyskinesia with tetrabenazine, clonazepam skand clozapine combined: a naturalistic long-term follow-up study. J. Neurol. 2012, 259:660-664.
40. Kiriakakis V., Bhatia K.P., Quinn N.P., Marsden C.D. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 121 resolution of tardive dystonia in a patient with bipolar disorder treated with clozapine: a case report. Prog. Neuro-Psychophamacol. Biol. Psychiatr. 1998, 34:238-239.
41. Kwan Y., Sim K. Resolution of tardive dystonia in a patient with bipolar disorder treated with clozapine: a case report. Prog. Neuro-Psychophamacol. Biol. Psychiatr. 2010, 34:238-239.
42. Kyriakos D., Bozikas V.P., Garyfallos G., Lavrentiadis G., Giouzepas J., Fokas K. Tardive nocturnal akathisia due to clozapine treatment. Int. J. Psychiatr. Med. 2005, 35:207-211.
43. Lamberti J.S., Bellnier T. Clozapine and tardive dystonia. J. Nerv. Ment. Dis. 1993, 181:137-138.
44. Larach V.W., Zamboni R.T., Mancini H.R., Mancini R.R., Gallardo R.T. New strategies for old problems: tardive dyskinesia (TD). Review and report on severe TD cases treated withclozapine with 12, 8 and 5 years of video follow-up. Schizophr. Res. 1997, 28:231-246.
45. Leppig M., Bosch B., Naber D., Hippius H. Clozapine in the treatment of 121 out-patients. Psychopharmacol. (Berl.) 1989, 99:S77-S79.
46. Levin H., Chengappa K.N., Kambhampati R.K., Mahdavi N., Ganguli R. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?. J. Clin. Psychiatr. 1992, 53:248-251.
47. Levkovitch Y., Kronenberg J., Kayser N., Zvyagelski M., Gaoni B., Gadoth N. Clozapine for tardive dyskinesia in adolescents. Brain Dev. 1995, 17:213-215.
48. Li C.R., Chung Y.C., Park T.W., Yang J.C., Kim K.W., Lee K.H., Hwang I.K. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug. World J. Biol. Psychiatr. 2009, 10:919-924.
49. Lieberman J.A., Saltz B.L., Johns C.A., Pollack S., Borenstein M., Kane J. The effects of clozapine on tardive dyskinesia. Br. J. Psychiatr. 1991, 158:503-510.
50. Littrell K., Magill A.M. The effect of clozapine on pre-existing tardive dyskinesia. J. Psychosoc. Nurs. Ment. Health Serv. 1993, 31:14-18.
51. Lohr J.B., Kuczenski R., Niculescu A.B. Oxidative mechanisms and tardive dyskinesia. CNS Drugs 2003, 17:47-62.
52. Loonen A.J., Ivanova S.A. New insights into the mechanism of drug-induced dyskinesia. CNS Spectr. 2013, 18:15-20.
53. Louza M.R., Bassitt D.P. Maintenance Treatment of severe tardive dyskinesia with clozapine 5 years' follow-up. J. Clin. Psychopharmacol. 2005, 25:180-182.
54. Margolese H.C., Chouinard G., Kolivakis T.T., Beauclair L., Miller R. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction. Can. J. Psychiatr. 2005, 50:541-547.
55. Maurer I., Grunwald T., Elger C.E. Clozapine treatment of delayed-onset paroxysmal hemidystonia. Mov. Disord. 1998, 13:614-616.
56. Meltzer H.Y., Luchins D.J. Effect of clozapine in severe tardive dyskinesia: a case report. J. Clin. Psychopharmacol. 1984, 4:286-287.
57. Mendhekar D.N., Andrade C. Prochlorperazine-induced tardive dystonia and its worsening with clozapine in a non-mentally ill patient with migraine. Ann. Pharmacother. 2011, 45:545-546.
58. Miller R., Chouinard G. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia. Biol. Psychiatr. 1993, 34:713-738.
59. Miller D.D. Clozapine and tardive dyskinesia. Am. J. Psychiatr. 2003, 160:588.
60. Modestin J., Stephan P.L., Erni T., Umari T. Prevalence of extrapyramidal syndromes in psychiatric in patients and the relationship of clozapine treatment to tardive dyskinesia. Schizophr. Res. 2000, 42:223-230.
61. Modestin J., Wehrli M.V., Stephan P.L., Agarwalla P. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment. Schizophr. Res. 2008, 100:97-107.
62. Moghaddam B., Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J. Neurochem. 1990, 54:1755-1760.
63. Molho E.S., Factor S.A. Possible tardive dystonia resulting from clozapine therapy. Mov. Disord. 1999, 14:873-874.
64. Naber D., Leppig M., Grohmann R., Hippius H. Efficacy and adverse effects of clozapine in the treatment of schizophrenia and tardive dyskinesia - a retrospective study of 387 patients. Psychopharmacol. (Berl.) 1989, 99:S73-S76.
65. Nair C., Abraham G., De Leon J., Stanilla J.K., Josiassen R.C., Simpson G. Dose related effects of clozapine on tardive dyskinesia among treatment refractory patients with schizophrenia. Biol. Psychiatr. 1996, 39:529.
66. Novick D., Haro J.M., Perrin E., Suarez D., Texeira J.M. Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. Eur. Neuropsychopharmacol. 2009, 19:542-550.
67. Novick D., Haro J.M., Bertsch J., Haddad P.M. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six month results from the European Schizophrenia Outpatient Health Outcomes Study. J. Clin. Psychopharmacol. 2010, 30:531-540.
68. Pekkan G., Kilicoglu A., Algin D.I. Treatment of a tardive dyskinesia patient with temporomandibular disorder: a case report. J. Orofac. Pain 2010, 24:212-216.
69. Pinninti N.R., Desantis M.J., Adityanjee A. Effectiveness of clozapine in treating severe tardive dystonia and associated pyosis. J. Neuropsychiatr. Clin. Neurosci. 2012, 24:E5-E6.
70. Raguraman J., Vijaysagar J. Worsening of tardive dyskinesia due to clozapine therapy. J. Postgrad. Med. 2007, 53:218.
71. Raja M., Maisto G., Altavista M.C., Albanese A. Tardive lingual dystonia treated with clozapine. Mov. Disord. 1996, 11:585-586.
72. Richelson E. Receptor pharmacology of neuroleptics: relation to clinical effects. J. Clin. Psychiatr. 1999, 60(suppl 10):5-14.
73. Rosenheck R., Cramer J., Xu W., Thomas J., Henderson W., Frisman L., Fye C., Charney D. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. N. Engl. J. Med. 1997, 337:809-815.
74. Sacchetti E., Valsecchi P. Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. Int. Clin. Psychopharmacol. 2003, 18:357-359.
75. Schonecker M. Paroxysmal dyskinesia as the effect of megaphen. Nervenarzt 1957, 28:550-553.
76. Shapleske J., Mickay A.P., Mckenna P.J. Successful treatment of tardive dystonia with clozapine and clonazepam. Br. J. Psychiatr. 1996, 168:516-518.
77. Shrivastava M., Solanke B., Dakhale G., Somani A., Waradkar P. Relapse of tardive dyskinesia due to reduction in clozapine dose. Indian J. Pharmacol. 2009, 41:201-202.
78. Simpson G.M., Lee J.H., Shrivastava R.K. Clozapine in tardive dyskinesia. Psychopharmacol. (Berl.) 1978, 56:75-80.
79. Small J.G., Milstein V., Marhenke J.D., Hall D.D., Kellams J.J. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis. J. Clin. Psychiatr. 1987, 48:263-267.
80. Spivak B., Mester R., Abesgaus J., Wittenberg N., Adlersberg S., Gonen N., Weizman A. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. J. Clin. Psychiatr. 1997, 58:318-322.
81. Tamminga C.A., Thaker G.K., Moran M., Kakigi T., Gao X.M. Clozapine in tardive dyskinesia: observations from human and animal model studies. J. Clin. Psychiatr. 1994, 55(suppl B):102-106.
82. Tamminga C.A., Lahti A.C. The new generation of antipsychotic drugs. Int. Clin. Psychopharmacol. 1996, 11(suppl 2):73-76.
83. Towbin K.E., Dykens E.M., Pugliese R.G. Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome. J. Am. Acad. Child Adolesc. Psychiatr. 1994, 33:651-657.
84. Trugman J.M., Leadbetter R., Zalis M.E., Burgdorf R.O., Wooten G.F. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Mov. Disord. 1994, 9:441-446.
85. Uzun O., Cansever A., Ozsahin A. A case of relapsed tardive dyskinesia due to clozapine dose reduction. Int. Clin. Psychopharmacol. 2001, 16:369-371.
86. Uzun O., Doruk A. Tardive oculogyric crisis during treatment with clozapine: report of three cases. Clin. Drug Invest. 2007, 27:861-864.
87. Van Harten P.N., Kamphuis D.J., Matroos G.E. Use of clozapine in tardive dystonia. Prog. Neuro-Psychophamacol. Biol. Psychiatr. 1996, 20:263-274.
88. Van Putten T., Wirshing W.C., Marder S.R. Tardive meige syndrome responsive to clozapine. J. Clin. Psychopharmacol. 1990, 10:381-382.
89. Wilson W.H. Clinical Review of clozapine treatment in a state hospital. Hosp. Commun. Psychiatr. 1992, 43:700-703.
90. Wirshing W.C., Phelan C.K., Van Putten T., Marder S.R., Engel J. Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesia. J. Clin. Psychopharmacol. 1990, 10:371-373.
91. Yassa R., Jeste D.V. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr. Bull. 1992, 18:701-715.
92. Yovtcheva S.P., Stanley-Tilt C., Moles J.K. Reemergence of tardive dyskinesia after discontinuation of clozapine treatment. Schizophr. Res. 2000, 46:107-109.